Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis.

Vasilogianni, Areti-Maria; Al-Majdoub, Zubida M; Achour, Brahim; Peters, Sheila Annie; Rostami-Hodjegan, Amin; Barber, Jill.

Afiliação

Vasilogianni AM; Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
Al-Majdoub ZM; Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
Achour B; Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
Peters SA; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.
Rostami-Hodjegan A; Translational Quantitative Pharmacology, BioPharma, R&D Global Early Development, Merck KGaA, Darmstadt, Germany.
Barber J; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co., KG, Ingelheim am Rhein, Germany.

Front Oncol ; 13: 1010563, 2023.

Article em En | MEDLINE | ID: mdl-36890818